| Ytd | -4.17% | |
| 1y | -13.08% |
| Open | 1.53 | Prev Close | 1.54 | Low | 1.50 | High | 1.53 | Mkt Cap | 170.98M |
| Vol | 18.02K | Avg Vol | 732.51K | EPS | -1.19 | P/E | -1.29 | Forward P/E | -1.25 |
| Beta | 0.60 | Short Ratio | 3.92 | Inst. Own | 95.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 1.85 | 200-d Avg | 1.95 | 1yr Est | 5.51 |
ALEC News
GSK-backed Ris-Rez posts positive Phase 3 survival data in small-cell lung cancer as the company mov
Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement coverin
Alector (ALEC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earning
--Independent data monitoring committee (IDMC) determined the trial unlikely to meet primary endpoin
Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Ene
After reaching an important support level, Alector, Inc. (ALEC) could be a good stock pick from a te
Three health-technology names are drawing fresh analyst attention this week as strategic partnership
Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Alector (ALEC) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clini
Milestone Pharmaceuticals (NASDAQ: MIST - Get Free Report) and Alector (NASDAQ: ALEC - Get Free Repo
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Alector, Inc. (NASDAQ
Alector, Inc. (NASDAQ: ALEC - Get Free Report) has been assigned an average rating of "Reduce" from
Alector, Inc. (NASDAQ: ALEC - Get Free Report) was the target of a significant growth in short inter
Alector, Inc. (NASDAQ: ALEC - Get Free Report)'s stock price was up 4.8% during trading on Monday. T
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clini
Alector, Inc. (ALEC) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript
SOUTH SAN FRANCISCO, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clini
LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights li
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s sessi
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
On Monday, 721 companies achieved new lows for the year.
On Friday, 431 companies hit new 52-week lows.
Tuesday's session saw 729 companies set new 52-week lows.